Chen L, Pankiewicz KW (2007). Recent development of IMP dehydrogenase inhibitors for the treatment of cancer. Curr. Opin. Drug Discov. Dev. 10(4):403-412.

Decottignies A, Sanchez-Perez I, Nurse P (2003). Schizosaccharomyces pombe essential genes: a pilot study. Genome Res. 13:399-406.
Crossref

Fernández-Álvarez A, Elías-Villalobos A, Ibeas JI (2009). The O-mannosyltransferase PMT4 is essential for normal appressorium formation and penetration in Ustilago maydis. Plant Cell 21:3397-3412.
Crossref

Gardner JM, Jaspersen SL (2014). Manupulating the yeast genome: deletion, mutation, and tagging by PCR. Methods Mol. Biol. 1205:45-78.
Crossref

Gregan J, Rabitsch PK, Rumpf C, Novatchkova M, Schleiffer A, Nasmyth K (2006). High-throughput knockout screen in fission yeast. Nat. Protoc. 1(5):2457-2464.
Crossref

Gutz H, Heslot H, Leupold U, Loprieno N (1974). Schizosaccharomyces

Hentges P, Van Driessche B, Tafforeau L, Vandenhaute J, Carr AM (2005). Three novel antibiotic marker cassettes for gene disruption and marker switching in Schizosaccharomyces pombe. Yeast 22(13):1013-1019.
Crossref

Hoffman CS, Wood V, Fantes PA (2015). An ancient yeast for young geneticists: a primer on the Schizosaccharomyces pombe model system. Genetics 201:403-423.
Crossref

Jiang L, Zhao J, Guo R, Li J, Yu L, Xu D (2010). Functional characterization and virulence study of ADE8 and GUA1 genes involved in the de novo purine biosynthesis in Candida albicans. Fems. Yeast Res. 10(2):199-208.
Crossref

Karaer S, Topal-Sarıkaya A, Arda N, Temizkan G (2006). The 3' terminal sequence of the inosine monophosphate dehydrogenase gene encodes an active domain in the yeast Schizosaccharomyces pombe. Genet. Mol. Biol. 29(3):551-557.
Crossref

Kaur R, Ingavale SS, Bachhawat AK (1997). PCR-mediated direct gene disruption in Schizosaccharomyces pombe. Nucleic Acids Res. 25:1080-1081.
Crossref

Kim DU, Hayles J, Kim D, Wood V, Park HO, Won M, Yoo HS, Duhig T, Nam M, Palmer G, Han S (2010). Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat. Biotechnol. 28:617-623.
Crossref

Nair V, Shu, Q (2007). Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antivir. Chem. Chemother. 18(5):245-258.
Crossref

Oláh E, Kokeny S, Papp J, Bozsik A, Keszei M (2006). Modulation of cancer pathways by inhibitors of guanylate metabolism. Adv. Enzyme Regul. 46:176-190.
Crossref

Palabiyik B, Jafari Ghods F, Karaer Uzuner S (2016). Role of glucose repression in the oxidative stress response of Schizosaccharomyces pombe: analysis of transcript levels of fbp1, hxk2, sod1 and ctt1 genes in sty1, atf1 and pap1 knock-out mutants. Turk. J. Biol. 40:815-825.
Crossref

Ratcliffe AJ (2006). Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases. Curr. Opin. Drug Discov. Dev. 9(5):595-605.

Rong YS, Golic KG (2000). Gene Targeting by Homologous Recombination in Drosophila. Science 288:2013-2017.
Crossref

Sawitzke JA, Thomason LC, Bubunenko M, Li X, Costantino N, Court DL (2013). Recombineering: using drug cassettes to knock out genes in vivo. Methods Enzymol. 533:79-102.
Crossref

Shen B, Xiao J, Dai L, Huang Y, Mao Z, Lin R, et al. (2015). Development of high-efficiency gene knockout system for Pochonia chlamydosporia. Microbiol. Res. 170:18-26.
Crossref

Shu Q, Nair V (2008). Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med. Res. Rev. 28:219-232.
Crossref

Spirek M, Benko Z, Carnecka M, Rumpf C, Cipak L, Batova M, Marova I, Nam M, Kim DU, Park HO, Hayles J (2010). S. pombe genome deletion project: an update. Cell Cycle 9(12):2399-2402.
Crossref

Suter B, Auerbach D, Stagljar I (2006). Yeast-based functional genomics and proteomics technologies: the first 15 years and beyond. Biotechniques 40:625-644.
Crossref

Wood V, Gwilliam R, Rajandream MA, Lyne M, Lyne R, Stewart A, Sgouros J, Peat N, Hayles J, Baker S, Basham D (2002). The genome sequence of Schizosaccharomyces pombe. Nature 415:871-880.
Crossref